Botanical Drug Industry Research Report 2023
Sales outsourcing is simply this: outsourcing a portion or entire sales activities to a trusted 3rd party sales team. Using a sales outsourcing partner allows companies to attract and maintain a sales force without having to make them full or part-time employees.
Highlights
The global Botanical Drug market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, etc. are the leaders of the industry.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 75% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 16%.
The classification of Botanical Drug includes Prescription Drug and OTC, and the proportion of OTC in 2019 was about 61%.
Botanical Drug is widely used for Cardiovascular, Tumor, Respiratory System, Others. The most proportion of Botanical Drug is Cardiovascular, and the proportion in 2019 was 30%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Botanical Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botanical Drug.
The Botanical Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Botanical Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Botanical Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
Product Type Insights
Global markets are presented by Botanical Drug type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Botanical Drug are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Botanical Drug segment by Type
Prescription Drug
OTC
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Botanical Drug market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the Botanical Drug market.
Botanical Drug Segment by Application
Cardiovascular
Tumor
Respiratory System
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Botanical Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botanical Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Botanical Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Botanical Drug industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botanical Drug.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Botanical Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?
Highlights
The global Botanical Drug market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, etc. are the leaders of the industry.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 75% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 16%.
The classification of Botanical Drug includes Prescription Drug and OTC, and the proportion of OTC in 2019 was about 61%.
Botanical Drug is widely used for Cardiovascular, Tumor, Respiratory System, Others. The most proportion of Botanical Drug is Cardiovascular, and the proportion in 2019 was 30%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Botanical Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botanical Drug.
The Botanical Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Botanical Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Botanical Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
Product Type Insights
Global markets are presented by Botanical Drug type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Botanical Drug are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Botanical Drug segment by Type
Prescription Drug
OTC
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Botanical Drug market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the Botanical Drug market.
Botanical Drug Segment by Application
Cardiovascular
Tumor
Respiratory System
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Botanical Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botanical Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Botanical Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Botanical Drug industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botanical Drug.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Botanical Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Botanical Drug by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Prescription Drug
1.2.3 OTC
2.3 Botanical Drug by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Cardiovascular
2.3.3 Tumor
2.3.4 Respiratory System
2.3.5 Others
2.4 Assumptions and Limitations
3 Botanical Drug Breakdown Data by Type
3.1 Global Botanical Drug Historic Market Size by Type (2018-2023)
3.2 Global Botanical Drug Forecasted Market Size by Type (2023-2028)
4 Botanical Drug Breakdown Data by Application
4.1 Global Botanical Drug Historic Market Size by Application (2018-2023)
4.2 Global Botanical Drug Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Botanical Drug Market Perspective (2018-2029)
5.2 Global Botanical Drug Growth Trends by Region
5.2.1 Global Botanical Drug Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Botanical Drug Historic Market Size by Region (2018-2023)
5.2.3 Botanical Drug Forecasted Market Size by Region (2024-2029)
5.3 Botanical Drug Market Dynamics
5.3.1 Botanical Drug Industry Trends
5.3.2 Botanical Drug Market Drivers
5.3.3 Botanical Drug Market Challenges
5.3.4 Botanical Drug Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Botanical Drug Players by Revenue
6.1.1 Global Top Botanical Drug Players by Revenue (2018-2023)
6.1.2 Global Botanical Drug Revenue Market Share by Players (2018-2023)
6.2 Global Botanical Drug Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Botanical Drug Head office and Area Served
6.4 Global Botanical Drug Players, Product Type & Application
6.5 Global Botanical Drug Players, Date of Enter into This Industry
6.6 Global Botanical Drug Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Botanical Drug Market Size (2018-2029)
7.2 North America Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Botanical Drug Market Size by Country (2018-2023)
7.4 North America Botanical Drug Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Botanical Drug Market Size (2018-2029)
8.2 Europe Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Botanical Drug Market Size by Country (2018-2023)
8.4 Europe Botanical Drug Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Botanical Drug Market Size (2018-2029)
9.2 Asia-Pacific Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Botanical Drug Market Size by Country (2018-2023)
9.4 Asia-Pacific Botanical Drug Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Botanical Drug Market Size (2018-2029)
10.2 Latin America Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Botanical Drug Market Size by Country (2018-2023)
10.4 Latin America Botanical Drug Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Botanical Drug Market Size (2018-2029)
11.2 Middle East & Africa Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Botanical Drug Market Size by Country (2018-2023)
11.4 Middle East & Africa Botanical Drug Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Buchang Pharmaceuticals
11.1.1 Buchang Pharmaceuticals Company Detail
11.1.2 Buchang Pharmaceuticals Business Overview
11.1.3 Buchang Pharmaceuticals Botanical Drug Introduction
11.1.4 Buchang Pharmaceuticals Revenue in Botanical Drug Business (2017-2022)
11.1.5 Buchang Pharmaceuticals Recent Development
11.2 China TCM
11.2.1 China TCM Company Detail
11.2.2 China TCM Business Overview
11.2.3 China TCM Botanical Drug Introduction
11.2.4 China TCM Revenue in Botanical Drug Business (2017-2022)
11.2.5 China TCM Recent Development
11.3 Tsumura
11.3.1 Tsumura Company Detail
11.3.2 Tsumura Business Overview
11.3.3 Tsumura Botanical Drug Introduction
11.3.4 Tsumura Revenue in Botanical Drug Business (2017-2022)
11.3.5 Tsumura Recent Development
11.4 Schwabe
11.4.1 Schwabe Company Detail
11.4.2 Schwabe Business Overview
11.4.3 Schwabe Botanical Drug Introduction
11.4.4 Schwabe Revenue in Botanical Drug Business (2017-2022)
11.4.5 Schwabe Recent Development
11.5 Tong Ren Tang
11.5.1 Tong Ren Tang Company Detail
11.5.2 Tong Ren Tang Business Overview
11.5.3 Tong Ren Tang Botanical Drug Introduction
11.5.4 Tong Ren Tang Revenue in Botanical Drug Business (2017-2022)
11.5.5 Tong Ren Tang Recent Development
11.6 Jumpcan Pharmaceutical
11.6.1 Jumpcan Pharmaceutical Company Detail
11.6.2 Jumpcan Pharmaceutical Business Overview
11.6.3 Jumpcan Pharmaceutical Botanical Drug Introduction
11.6.4 Jumpcan Pharmaceutical Revenue in Botanical Drug Business (2017-2022)
11.6.5 Jumpcan Pharmaceutical Recent Development
11.7 Guangzhou Baiyunshan Pharmaceutical
11.7.1 Guangzhou Baiyunshan Pharmaceutical Company Detail
11.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
11.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Introduction
11.7.4 Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical Drug Business (2017-2022)
11.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Development
11.8 Yunnan Baiyao
11.8.1 Yunnan Baiyao Company Detail
11.8.2 Yunnan Baiyao Business Overview
11.8.3 Yunnan Baiyao Botanical Drug Introduction
11.8.4 Yunnan Baiyao Revenue in Botanical Drug Business (2017-2022)
11.8.5 Yunnan Baiyao Recent Development
11.9 Tasly Holding Group
11.9.1 Tasly Holding Group Company Detail
11.9.2 Tasly Holding Group Business Overview
11.9.3 Tasly Holding Group Botanical Drug Introduction
11.9.4 Tasly Holding Group Revenue in Botanical Drug Business (2017-2022)
11.9.5 Tasly Holding Group Recent Development
11.10 Bionorica Se
11.10.1 Bionorica Se Company Detail
11.10.2 Bionorica Se Business Overview
11.10.3 Bionorica Se Botanical Drug Introduction
11.10.4 Bionorica Se Revenue in Botanical Drug Business (2017-2022)
11.10.5 Bionorica Se Recent Development
11.11 Huarun 999
11.11.1 Huarun 999 Company Detail
11.11.2 Huarun 999 Business Overview
11.11.3 Huarun 999 Botanical Drug Introduction
11.11.4 Huarun 999 Revenue in Botanical Drug Business (2017-2022)
11.11.5 Huarun 999 Recent Development
11.12 Taiji
11.12.1 Taiji Company Detail
11.12.2 Taiji Business Overview
11.12.3 Taiji Botanical Drug Introduction
11.12.4 Taiji Revenue in Botanical Drug Business (2017-2022)
11.12.5 Taiji Recent Development
11.13 Weleda
11.13.1 Weleda Company Detail
11.13.2 Weleda Business Overview
11.13.3 Weleda Botanical Drug Introduction
11.13.4 Weleda Revenue in Botanical Drug Business (2017-2022)
11.13.5 Weleda Recent Development
11.14 Kwangdong
11.14.1 Kwangdong Company Detail
11.14.2 Kwangdong Business Overview
11.14.3 Kwangdong Botanical Drug Introduction
11.14.4 Kwangdong Revenue in Botanical Drug Business (2017-2022)
11.14.5 Kwangdong Recent Development
11.15 GW Pharmaceuticals
11.15.1 GW Pharmaceuticals Company Detail
11.15.2 GW Pharmaceuticals Business Overview
11.15.3 GW Pharmaceuticals Botanical Drug Introduction
11.15.4 GW Pharmaceuticals Revenue in Botanical Drug Business (2017-2022)
11.15.5 GW Pharmaceuticals Recent Development
13 Report Conclusion
14 Disclaimer
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Botanical Drug by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Prescription Drug
1.2.3 OTC
2.3 Botanical Drug by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Cardiovascular
2.3.3 Tumor
2.3.4 Respiratory System
2.3.5 Others
2.4 Assumptions and Limitations
3 Botanical Drug Breakdown Data by Type
3.1 Global Botanical Drug Historic Market Size by Type (2018-2023)
3.2 Global Botanical Drug Forecasted Market Size by Type (2023-2028)
4 Botanical Drug Breakdown Data by Application
4.1 Global Botanical Drug Historic Market Size by Application (2018-2023)
4.2 Global Botanical Drug Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Botanical Drug Market Perspective (2018-2029)
5.2 Global Botanical Drug Growth Trends by Region
5.2.1 Global Botanical Drug Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Botanical Drug Historic Market Size by Region (2018-2023)
5.2.3 Botanical Drug Forecasted Market Size by Region (2024-2029)
5.3 Botanical Drug Market Dynamics
5.3.1 Botanical Drug Industry Trends
5.3.2 Botanical Drug Market Drivers
5.3.3 Botanical Drug Market Challenges
5.3.4 Botanical Drug Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Botanical Drug Players by Revenue
6.1.1 Global Top Botanical Drug Players by Revenue (2018-2023)
6.1.2 Global Botanical Drug Revenue Market Share by Players (2018-2023)
6.2 Global Botanical Drug Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Botanical Drug Head office and Area Served
6.4 Global Botanical Drug Players, Product Type & Application
6.5 Global Botanical Drug Players, Date of Enter into This Industry
6.6 Global Botanical Drug Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Botanical Drug Market Size (2018-2029)
7.2 North America Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Botanical Drug Market Size by Country (2018-2023)
7.4 North America Botanical Drug Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Botanical Drug Market Size (2018-2029)
8.2 Europe Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Botanical Drug Market Size by Country (2018-2023)
8.4 Europe Botanical Drug Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Botanical Drug Market Size (2018-2029)
9.2 Asia-Pacific Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Botanical Drug Market Size by Country (2018-2023)
9.4 Asia-Pacific Botanical Drug Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Botanical Drug Market Size (2018-2029)
10.2 Latin America Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Botanical Drug Market Size by Country (2018-2023)
10.4 Latin America Botanical Drug Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Botanical Drug Market Size (2018-2029)
11.2 Middle East & Africa Botanical Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Botanical Drug Market Size by Country (2018-2023)
11.4 Middle East & Africa Botanical Drug Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Buchang Pharmaceuticals
11.1.1 Buchang Pharmaceuticals Company Detail
11.1.2 Buchang Pharmaceuticals Business Overview
11.1.3 Buchang Pharmaceuticals Botanical Drug Introduction
11.1.4 Buchang Pharmaceuticals Revenue in Botanical Drug Business (2017-2022)
11.1.5 Buchang Pharmaceuticals Recent Development
11.2 China TCM
11.2.1 China TCM Company Detail
11.2.2 China TCM Business Overview
11.2.3 China TCM Botanical Drug Introduction
11.2.4 China TCM Revenue in Botanical Drug Business (2017-2022)
11.2.5 China TCM Recent Development
11.3 Tsumura
11.3.1 Tsumura Company Detail
11.3.2 Tsumura Business Overview
11.3.3 Tsumura Botanical Drug Introduction
11.3.4 Tsumura Revenue in Botanical Drug Business (2017-2022)
11.3.5 Tsumura Recent Development
11.4 Schwabe
11.4.1 Schwabe Company Detail
11.4.2 Schwabe Business Overview
11.4.3 Schwabe Botanical Drug Introduction
11.4.4 Schwabe Revenue in Botanical Drug Business (2017-2022)
11.4.5 Schwabe Recent Development
11.5 Tong Ren Tang
11.5.1 Tong Ren Tang Company Detail
11.5.2 Tong Ren Tang Business Overview
11.5.3 Tong Ren Tang Botanical Drug Introduction
11.5.4 Tong Ren Tang Revenue in Botanical Drug Business (2017-2022)
11.5.5 Tong Ren Tang Recent Development
11.6 Jumpcan Pharmaceutical
11.6.1 Jumpcan Pharmaceutical Company Detail
11.6.2 Jumpcan Pharmaceutical Business Overview
11.6.3 Jumpcan Pharmaceutical Botanical Drug Introduction
11.6.4 Jumpcan Pharmaceutical Revenue in Botanical Drug Business (2017-2022)
11.6.5 Jumpcan Pharmaceutical Recent Development
11.7 Guangzhou Baiyunshan Pharmaceutical
11.7.1 Guangzhou Baiyunshan Pharmaceutical Company Detail
11.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
11.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Introduction
11.7.4 Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical Drug Business (2017-2022)
11.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Development
11.8 Yunnan Baiyao
11.8.1 Yunnan Baiyao Company Detail
11.8.2 Yunnan Baiyao Business Overview
11.8.3 Yunnan Baiyao Botanical Drug Introduction
11.8.4 Yunnan Baiyao Revenue in Botanical Drug Business (2017-2022)
11.8.5 Yunnan Baiyao Recent Development
11.9 Tasly Holding Group
11.9.1 Tasly Holding Group Company Detail
11.9.2 Tasly Holding Group Business Overview
11.9.3 Tasly Holding Group Botanical Drug Introduction
11.9.4 Tasly Holding Group Revenue in Botanical Drug Business (2017-2022)
11.9.5 Tasly Holding Group Recent Development
11.10 Bionorica Se
11.10.1 Bionorica Se Company Detail
11.10.2 Bionorica Se Business Overview
11.10.3 Bionorica Se Botanical Drug Introduction
11.10.4 Bionorica Se Revenue in Botanical Drug Business (2017-2022)
11.10.5 Bionorica Se Recent Development
11.11 Huarun 999
11.11.1 Huarun 999 Company Detail
11.11.2 Huarun 999 Business Overview
11.11.3 Huarun 999 Botanical Drug Introduction
11.11.4 Huarun 999 Revenue in Botanical Drug Business (2017-2022)
11.11.5 Huarun 999 Recent Development
11.12 Taiji
11.12.1 Taiji Company Detail
11.12.2 Taiji Business Overview
11.12.3 Taiji Botanical Drug Introduction
11.12.4 Taiji Revenue in Botanical Drug Business (2017-2022)
11.12.5 Taiji Recent Development
11.13 Weleda
11.13.1 Weleda Company Detail
11.13.2 Weleda Business Overview
11.13.3 Weleda Botanical Drug Introduction
11.13.4 Weleda Revenue in Botanical Drug Business (2017-2022)
11.13.5 Weleda Recent Development
11.14 Kwangdong
11.14.1 Kwangdong Company Detail
11.14.2 Kwangdong Business Overview
11.14.3 Kwangdong Botanical Drug Introduction
11.14.4 Kwangdong Revenue in Botanical Drug Business (2017-2022)
11.14.5 Kwangdong Recent Development
11.15 GW Pharmaceuticals
11.15.1 GW Pharmaceuticals Company Detail
11.15.2 GW Pharmaceuticals Business Overview
11.15.3 GW Pharmaceuticals Botanical Drug Introduction
11.15.4 GW Pharmaceuticals Revenue in Botanical Drug Business (2017-2022)
11.15.5 GW Pharmaceuticals Recent Development
13 Report Conclusion
14 Disclaimer